| Product NDC: | 54868-5046 | 
| Proprietary Name: | Uroxatral | 
| Non Proprietary Name: | alfuzosin hydrochloride | 
| Active Ingredient(s): | 10 mg/1 & nbsp; alfuzosin hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 54868-5046 | 
| Labeler Name: | Physicians Total Care, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021287 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20040622 | 
| Package NDC: | 54868-5046-1 | 
| Package Description: | 10 TABLET, EXTENDED RELEASE in 1 BOTTLE (54868-5046-1) | 
| NDC Code | 54868-5046-1 | 
| Proprietary Name | Uroxatral | 
| Package Description | 10 TABLET, EXTENDED RELEASE in 1 BOTTLE (54868-5046-1) | 
| Product NDC | 54868-5046 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | alfuzosin hydrochloride | 
| Dosage Form Name | TABLET, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20040622 | 
| Marketing Category Name | NDA | 
| Labeler Name | Physicians Total Care, Inc. | 
| Substance Name | ALFUZOSIN HYDROCHLORIDE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |